NCT05591053View on ClinicalTrials.gov

Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Esophagus CancerEsophageal CancerEsophageal NeoplasmsEsophageal DiseasesEsophageal AdenocarcinomaEsophageal Squamous Cell CarcinomaEsophagus SCCEsophagus TumorEsophagus AdenocarcinomaEsophagus Neoplasm
Interventions
DEVICE

ActivSight

Use of ActivSight in patients undergoing laparoscopic or robot assisted esophagectomy.

Trial Locations (2)

15213

RECRUITING

University of Pittsburgh Medical Center - Dept of Cardiothoracic Surgery, Pittsburgh

15224

NOT_YET_RECRUITING

West Penn Hospital / Allegheny Health Network, Pittsburgh

Sponsors

Lead Sponsor

Activ Surgical
All Listed Sponsors
collaborator

University of Pittsburgh Medical Center

OTHER

collaborator

West Penn Allegheny Health System

OTHER

lead

Activ Surgical

INDUSTRY